🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA March 2026 enforcement update — compounding pharmacies Page 3

FDA March 2026 enforcement update — compounding pharmacies

RegAffairsDC Fri, Dec 1, 2023 at 4:00 PM 275 replies 54,177 viewsPage 3 of 20
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Dec 1, 2023 at 8:15 PM#11

+1. This mirrors my journey exactly. The FDA March 2026 discussion here is so valuable.

14 13Dr.LipidDallas, alex_tucson, kevin_tulsa and 11 others
Reply Quote Save Share Report
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Dec 1, 2023 at 8:32 PM#12

Reading this thread on FDA March 2026 hits close to home. Night shift nurse — I started at 287 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 62 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about FDA March 2026 — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Dec 1, 2023 at 10:32 PM
34 6Dr.SleepRoch, laura_annarbor, JenMemphis and 31 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 1, 2023 at 8:49 PM#13

Moderator note: Reminder: nothing posted here constitutes medical advice. Consult your healthcare provider.

Tagging this for the weekly digest. 👍

Last edited: Dec 2, 2023 at 12:49 AM
32 4RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 29 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Dec 1, 2023 at 9:06 PM#14

Relevant to FDA March 2026 enforcement — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 199 → 99 mg/dL, hsCRP 6.0 → 1.1 mg/L. All on tirzepatide for 15 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Last edited: Dec 1, 2023 at 11:06 PM
38 7bri_stats, pete_manc_UK, anna.melb_AU and 35 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Dec 1, 2023 at 9:23 PM#15

Congrats tammy_FL!! Keep going — you're doing incredible. 🎉

42 1wei_SG, cory_ATX, lori_vegas and 39 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register